Corrigendum to "Estimating the global inventory of deprioritized clinical-stage drug development programs: toward a market for shelved assets" [Drug Discov. Today 31(4) 2026 104723].
- DOI
- 10.1016/j.drudis.2026.104747
- Published
- 2026 Sep
- Container
- Drug discovery today
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.drudis.2026.104747,
title = {Corrigendum to "Estimating the global inventory of deprioritized clinical-stage drug development programs: toward a market for shelved assets" [Drug Discov. Today 31(4) 2026 104723].},
author = {Bakker A and Carino T and Cho J and Hammoudeh M and Krieger JL and Lewis-Hall F and Lo AW and Thakor RT},
year = {2026},
journal = {Drug discovery today},
doi = {10.1016/j.drudis.2026.104747},
url = {https://doi.org/10.1016/j.drudis.2026.104747}
}RIS
TY - JOUR TI - Corrigendum to "Estimating the global inventory of deprioritized clinical-stage drug development programs: toward a market for shelved assets" [Drug Discov. Today 31(4) 2026 104723]. AU - Bakker A AU - Carino T AU - Cho J AU - Hammoudeh M AU - Krieger JL AU - Lewis-Hall F AU - Lo AW AU - Thakor RT PY - 2026 JO - Drug discovery today DO - 10.1016/j.drudis.2026.104747 UR - https://doi.org/10.1016/j.drudis.2026.104747 ER -
APA
A, B., T, C., J, C., M, H., JL, K., F, L., AW, L., & RT, T. (2026). Corrigendum to "Estimating the global inventory of deprioritized clinical-stage drug development programs: toward a market for shelved assets" [Drug Discov. Today 31(4) 2026 104723].. Drug discovery today. https://doi.org/10.1016/j.drudis.2026.104747
Source records
- pubmed · retrieved 2026-09-25T16:19:34.511Z